COVID-19疫情期间头颈黏膜恶性肿瘤管理的循证指南
该综述基于PubMed检索及耳鼻咽喉科期刊手工检索,结合国家机构指南,评估COVID-19疫情期间头颈黏膜恶性肿瘤治疗的现有证据。结论指出患者仍需持续治疗,但应在各阶段尽量减少对患者和医护人员的风险,并节约有限资源。临床决策应依据最佳可用证据以优化结局并维持安全环境。
要点
- 头颈黏膜恶性肿瘤患者在疫情期间仍需持续治疗。
- 治疗各阶段须降低患者与医护人员风险并节约有限资源。
- 诊疗计划应基于最佳可用证据平衡结局与安全。
核心结论
- 头颈黏膜恶性肿瘤患者需继续治疗,同时最小化患者和医护风险并节约资源。
- 临床决策应依据最佳可用证据优化结局并维持安全环境。
研究设计与样本
- 综述:PubMed检索联合耳鼻咽喉科期刊手工检索及国家机构指南。
- 检索按PRISMA指南执行,分COVID-19与头颈肿瘤管理两组词及其组合。
主要发现
- 因疫情耳鼻咽喉科医生治疗头颈癌患者面临新挑战。
- 需关注该背景下治疗风险的增加。
临床怎么用
- 患者护理计划应基于最佳可用证据制定,以优化结局并维持安全环境。
- 治疗全阶段应注重减少患者与医护人员风险并节约有限资源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Due to the current coronavirus disease 2019 (COVID-19) pandemic, otolaryngologists face novel challenges when treating patients with head and neck cancer. The purpose of this review is to evaluate the current evidence surrounding the treatment of these patients during this pandemic and to provide evidence-based recommendations with attention to increased risk in this setting. DATA SOURCES: A review of the literature was performed with PubMed. Because recently published articles on this topic may not yet be indexed into PubMed, otolaryngology journals were hand searched for relevant articles. Guidelines from national organizations were reviewed to identify additional relevant sources of information. REVIEW METHODS: Two groups of search terms were created: one with terms related to COVID-19 and another with terms related to head and neck cancer and its management. Searches were performed of all terms in each group as well as combinations of terms between groups. Searches and subsequent exclusion of articles were performed in accordance with the PRISMA guidelines (Preferred Reporting Items for Systematic Reviews and Meta-analyses). Additional articles were identified after relevant journals and guidelines from national organizations were reviewed. CONCLUSIONS: Patients with head and neck mucosal malignancy require continued treatment despite the current pandemic state. Care must be taken at all stages of treatment to minimize the risk to patients and health care workers while maintaining focus on minimizing use of limited resources. IMPLICATIONS FOR PRACTICE: Patient care plans should be guided by best available evidence to optimize outcomes while maintaining a safe environment in the setting of this pandemic.
引用
- Crosby DL, Sharma A. Evidence-Based Guidelines for Management of Head and Neck Mucosal Malignancies during the COVID-19 Pandemic. Otolaryngol Head Neck Surg. 2020. PMID: 32340549. doi:10.1177/0194599820923623
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。